首页> 美国政府科技报告 >Letter Health Consultation: PCB in Breast Milk at Portland Harbor, Portland, Oregon, January 14, 2009.
【24h】

Letter Health Consultation: PCB in Breast Milk at Portland Harbor, Portland, Oregon, January 14, 2009.

机译:信健康咨询:2009年1月14日,俄勒冈州波特兰市波特兰港的母乳中的pCB。

获取原文

摘要

The April 2004 Progranunatic Work Plan for the Portland Harbor Site did not include a breast feeding exposure scenario. However, the work plan stated that 'Within the consurIlption fisher receptors, pregnant and nursing women are a subgroup of potential concern due to potential exposures to fetuses and nursing infants and will be discussed further with EPA and its partners.' In the December 5, 2005 Identification of Round 3 Data Gaps Memo, EPA identified a number of refinements that were necessary to complete the human health risk assessment including an assessment of persistent, bioaccumlative, toxic chemicals (PBTs) in breast milk. EPA noted that further discussion between EPA and its partners was required to determine which methods and exposure assumptions will be proposed to estimate exposures and to characterize the risks from this pathway. In EPA's January 15, 2008 comments on the Comprehensive Round 2 Site Summary and Data Gaps Report, EPA reiterated that the breast feeding exposure scenario should be included in the baseline risk assessment and further discussion was necessary. Toward that end, EPA requested assistance from the Environmental Health Assessment Program (EHAP, formerly SHINE) to develop recommendations on how to address the health risks for infants exposed to PCBs in breast milk in the context of the many health benefits of breast feeding. A summary of this important exposure pathway and a series of recommendations are presented below.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号